Nasogastric patients are usually treated with glucose-lowering medications with less risk of hypoglycemia and long-acting antihypertensive medications with less fluctuation in blood pressure. Nasogastric feeding patients usually have higher blood glucose throughout the day due to irregular eating, fluid or semi-liquid food, smaller overall carbohydrate intake, but higher glycemic index. In order to prevent hypoglycemia from occurring, control blood glucose throughout the day, and enable blood glucose to reach the standard smoothly, treatment is usually started by choosing a long-acting insulin with less risk of hypoglycemia, such as diethylstilbestrol, or oral hypoglycemic drugs that do not cause hypoglycemia. The treatment regimen is adjusted when meals are able to be taken, with the addition of premeal insulin or other medications. Antihypertensive medications for patients on nasal feeding are usually oral medications that can be injected directly into the stomach via nasal feeding, and only certain long-acting controlled-release or extended-release formulations, such as nifedipine controlled-release tablets, need to be selected. However, both antihypertensive and hypoglycemic drugs should be selected under the guidance of a specialist, and should not be used to adjust the treatment program or choice of medication on their own.